nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylsalicylic acid—AKR1C1—lung cancer	0.267	0.556	CbGaD
Acetylsalicylic acid—TP53—lung cancer	0.139	0.289	CbGaD
Acetylsalicylic acid—PTGS2—lung cancer	0.0272	0.0566	CbGaD
Acetylsalicylic acid—ALB—lung cancer	0.0242	0.0504	CbGaD
Acetylsalicylic acid—ABCB1—lung cancer	0.0231	0.0481	CbGaD
Acetylsalicylic acid—SLC22A7—Docetaxel—lung cancer	0.0193	0.0729	CbGbCtD
Acetylsalicylic acid—ALB—Gefitinib—lung cancer	0.0178	0.0675	CbGbCtD
Acetylsalicylic acid—SLC22A7—Methotrexate—lung cancer	0.0139	0.0526	CbGbCtD
Acetylsalicylic acid—PTGS2—Cisplatin—lung cancer	0.0123	0.0466	CbGbCtD
Acetylsalicylic acid—PTGS2—Etoposide—lung cancer	0.0121	0.0458	CbGbCtD
Acetylsalicylic acid—CYP2C19—Gefitinib—lung cancer	0.0116	0.0437	CbGbCtD
Acetylsalicylic acid—CYP2C19—Teniposide—lung cancer	0.0112	0.0424	CbGbCtD
Acetylsalicylic acid—ALB—Erlotinib—lung cancer	0.0105	0.0399	CbGbCtD
Acetylsalicylic acid—PTGS1—Etoposide—lung cancer	0.0102	0.0386	CbGbCtD
Acetylsalicylic acid—ABCB1—Topotecan—lung cancer	0.0102	0.0386	CbGbCtD
Acetylsalicylic acid—CYP2C9—Gefitinib—lung cancer	0.00961	0.0364	CbGbCtD
Acetylsalicylic acid—ALB—Irinotecan—lung cancer	0.00952	0.036	CbGbCtD
Acetylsalicylic acid—ABCB1—Gefitinib—lung cancer	0.00932	0.0353	CbGbCtD
Acetylsalicylic acid—CYP2C9—Teniposide—lung cancer	0.00931	0.0353	CbGbCtD
Acetylsalicylic acid—CYP2C8—Erlotinib—lung cancer	0.00814	0.0308	CbGbCtD
Acetylsalicylic acid—CYP2C8—Paclitaxel—lung cancer	0.00745	0.0282	CbGbCtD
Acetylsalicylic acid—ABCB1—Vinorelbine—lung cancer	0.00718	0.0272	CbGbCtD
Acetylsalicylic acid—SLC22A6—Methotrexate—lung cancer	0.00591	0.0224	CbGbCtD
Acetylsalicylic acid—CYP2C8—Etoposide—lung cancer	0.00589	0.0223	CbGbCtD
Acetylsalicylic acid—ABCB1—Crizotinib—lung cancer	0.00571	0.0216	CbGbCtD
Acetylsalicylic acid—ABCB1—Gemcitabine—lung cancer	0.00558	0.0211	CbGbCtD
Acetylsalicylic acid—ABCB1—Erlotinib—lung cancer	0.00551	0.0209	CbGbCtD
Acetylsalicylic acid—CYP2C9—Paclitaxel—lung cancer	0.0052	0.0197	CbGbCtD
Acetylsalicylic acid—ABCB1—Paclitaxel—lung cancer	0.00505	0.0191	CbGbCtD
Acetylsalicylic acid—ALB—Methotrexate—lung cancer	0.00504	0.0191	CbGbCtD
Acetylsalicylic acid—ABCB1—Irinotecan—lung cancer	0.00498	0.0188	CbGbCtD
Acetylsalicylic acid—ABCB1—Vinblastine—lung cancer	0.00443	0.0168	CbGbCtD
Acetylsalicylic acid—CYP2C9—Cisplatin—lung cancer	0.00418	0.0158	CbGbCtD
Acetylsalicylic acid—ABCB1—Cisplatin—lung cancer	0.00406	0.0154	CbGbCtD
Acetylsalicylic acid—ABCB1—Etoposide—lung cancer	0.00399	0.0151	CbGbCtD
Acetylsalicylic acid—ABCB1—Docetaxel—lung cancer	0.00365	0.0138	CbGbCtD
Acetylsalicylic acid—ABCB1—Doxorubicin—lung cancer	0.00272	0.0103	CbGbCtD
Acetylsalicylic acid—ABCB1—Methotrexate—lung cancer	0.00263	0.00997	CbGbCtD
Acetylsalicylic acid—TP53—mammary gland—lung cancer	0.00217	0.0466	CbGeAlD
Acetylsalicylic acid—HSPA5—mammary gland—lung cancer	0.00209	0.0449	CbGeAlD
Acetylsalicylic acid—RPS6KA3—mammary gland—lung cancer	0.00178	0.0383	CbGeAlD
Acetylsalicylic acid—EDNRA—mammary gland—lung cancer	0.00145	0.0311	CbGeAlD
Acetylsalicylic acid—TP53—respiratory system—lung cancer	0.00144	0.0311	CbGeAlD
Acetylsalicylic acid—NFKBIA—respiratory system—lung cancer	0.00142	0.0306	CbGeAlD
Acetylsalicylic acid—HSPA5—respiratory system—lung cancer	0.00139	0.03	CbGeAlD
Acetylsalicylic acid—TP53—epithelium—lung cancer	0.00121	0.026	CbGeAlD
Acetylsalicylic acid—TP53—bronchus—lung cancer	0.00119	0.0256	CbGeAlD
Acetylsalicylic acid—NFKBIA—epithelium—lung cancer	0.00119	0.0256	CbGeAlD
Acetylsalicylic acid—RPS6KA3—respiratory system—lung cancer	0.00119	0.0255	CbGeAlD
Acetylsalicylic acid—NFKBIA—bronchus—lung cancer	0.00117	0.0252	CbGeAlD
Acetylsalicylic acid—HSPA5—epithelium—lung cancer	0.00116	0.025	CbGeAlD
Acetylsalicylic acid—HSPA5—bronchus—lung cancer	0.00115	0.0247	CbGeAlD
Acetylsalicylic acid—TP53—trachea—lung cancer	0.00107	0.023	CbGeAlD
Acetylsalicylic acid—Mefenamic acid—AKR1C1—lung cancer	0.00105	0.382	CrCbGaD
Acetylsalicylic acid—NFKBIA—trachea—lung cancer	0.00105	0.0226	CbGeAlD
Acetylsalicylic acid—HSPA5—trachea—lung cancer	0.00103	0.0221	CbGeAlD
Acetylsalicylic acid—NFKBIA—cardiac atrium—lung cancer	0.000986	0.0212	CbGeAlD
Acetylsalicylic acid—RPS6KA3—bronchus—lung cancer	0.000975	0.021	CbGeAlD
Acetylsalicylic acid—HSPA5—cardiac atrium—lung cancer	0.000966	0.0208	CbGeAlD
Acetylsalicylic acid—RPS6KA3—trachea—lung cancer	0.000876	0.0189	CbGeAlD
Acetylsalicylic acid—IKBKB—respiratory system—lung cancer	0.000875	0.0188	CbGeAlD
Acetylsalicylic acid—TP53—bone marrow—lung cancer	0.000846	0.0182	CbGeAlD
Acetylsalicylic acid—Salicylic acid—AKR1C1—lung cancer	0.000845	0.306	CrCbGaD
Acetylsalicylic acid—NFKBIA—bone marrow—lung cancer	0.000833	0.0179	CbGeAlD
Acetylsalicylic acid—RPS6KA3—cardiac atrium—lung cancer	0.000823	0.0177	CbGeAlD
Acetylsalicylic acid—HSPA5—bone marrow—lung cancer	0.000816	0.0176	CbGeAlD
Acetylsalicylic acid—EDNRA—bronchus—lung cancer	0.000793	0.0171	CbGeAlD
Acetylsalicylic acid—TP53—lung—lung cancer	0.000767	0.0165	CbGeAlD
Acetylsalicylic acid—ALB—mammary gland—lung cancer	0.000766	0.0165	CbGeAlD
Acetylsalicylic acid—NFKBIA—lung—lung cancer	0.000754	0.0162	CbGeAlD
Acetylsalicylic acid—HSPA5—lung—lung cancer	0.000739	0.0159	CbGeAlD
Acetylsalicylic acid—IKBKB—bronchus—lung cancer	0.00072	0.0155	CbGeAlD
Acetylsalicylic acid—EDNRA—trachea—lung cancer	0.000712	0.0153	CbGeAlD
Acetylsalicylic acid—RPS6KA3—bone marrow—lung cancer	0.000695	0.015	CbGeAlD
Acetylsalicylic acid—EDNRA—cardiac atrium—lung cancer	0.000669	0.0144	CbGeAlD
Acetylsalicylic acid—RPS6KA3—lung—lung cancer	0.000629	0.0135	CbGeAlD
Acetylsalicylic acid—CYP2C8—mammary gland—lung cancer	0.000539	0.0116	CbGeAlD
Acetylsalicylic acid—TP53—lymph node—lung cancer	0.000524	0.0113	CbGeAlD
Acetylsalicylic acid—NFKBIA—lymph node—lung cancer	0.000516	0.0111	CbGeAlD
Acetylsalicylic acid—EDNRA—lung—lung cancer	0.000512	0.011	CbGeAlD
Acetylsalicylic acid—HSPA5—lymph node—lung cancer	0.000505	0.0109	CbGeAlD
Acetylsalicylic acid—TP53—Podofilox—Teniposide—lung cancer	0.000496	0.162	CbGdCrCtD
Acetylsalicylic acid—CYP2C9—mammary gland—lung cancer	0.000478	0.0103	CbGeAlD
Acetylsalicylic acid—IKBKB—lung—lung cancer	0.000465	0.01	CbGeAlD
Acetylsalicylic acid—RPS6KA3—lymph node—lung cancer	0.00043	0.00926	CbGeAlD
Acetylsalicylic acid—NFKBIA—Podofilox—Teniposide—lung cancer	0.000376	0.123	CbGdCrCtD
Acetylsalicylic acid—EDNRA—lymph node—lung cancer	0.00035	0.00753	CbGeAlD
Acetylsalicylic acid—NFKBIA—Paclitaxel—Docetaxel—lung cancer	0.000348	0.114	CbGdCrCtD
Acetylsalicylic acid—IKBKB—lymph node—lung cancer	0.000318	0.00684	CbGeAlD
Acetylsalicylic acid—TP53—Vincristine—Vinorelbine—lung cancer	0.000315	0.103	CbGdCrCtD
Acetylsalicylic acid—TP53—Podofilox—Etoposide—lung cancer	0.000295	0.0964	CbGdCrCtD
Acetylsalicylic acid—PTGS1—respiratory system—lung cancer	0.000291	0.00627	CbGeAlD
Acetylsalicylic acid—PTGS2—respiratory system—lung cancer	0.000278	0.00599	CbGeAlD
Acetylsalicylic acid—TP53—Vincristine—Vinblastine—lung cancer	0.000252	0.0825	CbGdCrCtD
Acetylsalicylic acid—PTGS1—epithelium—lung cancer	0.000243	0.00524	CbGeAlD
Acetylsalicylic acid—Salicylate-sodium—PTGS2—lung cancer	0.00024	0.087	CrCbGaD
Acetylsalicylic acid—NFKBIA—Vincristine—Vinorelbine—lung cancer	0.000239	0.0782	CbGdCrCtD
Acetylsalicylic acid—PTGS2—epithelium—lung cancer	0.000232	0.005	CbGeAlD
Acetylsalicylic acid—PTGS2—bronchus—lung cancer	0.000229	0.00493	CbGeAlD
Acetylsalicylic acid—NFKBIA—Podofilox—Etoposide—lung cancer	0.000223	0.0731	CbGdCrCtD
Acetylsalicylic acid—PTGS1—trachea—lung cancer	0.000215	0.00463	CbGeAlD
Acetylsalicylic acid—PTGS2—trachea—lung cancer	0.000206	0.00443	CbGeAlD
Acetylsalicylic acid—PTGS1—cardiac atrium—lung cancer	0.000202	0.00435	CbGeAlD
Acetylsalicylic acid—NFKBIA—Vincristine—Vinblastine—lung cancer	0.000191	0.0625	CbGdCrCtD
Acetylsalicylic acid—ALB—lymph node—lung cancer	0.000185	0.00399	CbGeAlD
Acetylsalicylic acid—ABCB1—respiratory system—lung cancer	0.000172	0.0037	CbGeAlD
Acetylsalicylic acid—PTGS2—bone marrow—lung cancer	0.000163	0.00351	CbGeAlD
Acetylsalicylic acid—PTGS1—lung—lung cancer	0.000155	0.00333	CbGeAlD
Acetylsalicylic acid—PTGS2—lung—lung cancer	0.000148	0.00318	CbGeAlD
Acetylsalicylic acid—ABCB1—epithelium—lung cancer	0.000144	0.0031	CbGeAlD
Acetylsalicylic acid—Salsalate—PTGS2—lung cancer	0.00014	0.0507	CrCbGaD
Acetylsalicylic acid—Meclofenamic acid—PTGS2—lung cancer	0.000138	0.05	CrCbGaD
Acetylsalicylic acid—ABCB1—trachea—lung cancer	0.000127	0.00274	CbGeAlD
Acetylsalicylic acid—Diabetes mellitus—Methotrexate—lung cancer	0.00012	0.00156	CcSEcCtD
Acetylsalicylic acid—Polyuria—Methotrexate—lung cancer	0.000118	0.00154	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Paclitaxel—lung cancer	0.000118	0.00154	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Paclitaxel—lung cancer	0.000118	0.00153	CcSEcCtD
Acetylsalicylic acid—Nausea—Teniposide—lung cancer	0.000117	0.00152	CcSEcCtD
Acetylsalicylic acid—Anaemia—Irinotecan—lung cancer	0.000116	0.00151	CcSEcCtD
Acetylsalicylic acid—Urticaria—Topotecan—lung cancer	0.000116	0.0015	CcSEcCtD
Acetylsalicylic acid—Coma—Doxorubicin—lung cancer	0.000113	0.00147	CcSEcCtD
Acetylsalicylic acid—Anaemia—Gemcitabine—lung cancer	0.000113	0.00147	CcSEcCtD
Acetylsalicylic acid—Vertigo—Irinotecan—lung cancer	0.000113	0.00147	CcSEcCtD
Acetylsalicylic acid—Syncope—Irinotecan—lung cancer	0.000113	0.00147	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Irinotecan—lung cancer	0.000113	0.00146	CcSEcCtD
Acetylsalicylic acid—Flushing—Etoposide—lung cancer	0.000112	0.00145	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Vinorelbine—lung cancer	0.000111	0.00144	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Irinotecan—lung cancer	0.000111	0.00144	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Vinblastine—lung cancer	0.00011	0.00143	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Paclitaxel—lung cancer	0.00011	0.00143	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Gemcitabine—lung cancer	0.00011	0.00143	CcSEcCtD
Acetylsalicylic acid—Flushing—Paclitaxel—lung cancer	0.000109	0.00142	CcSEcCtD
Acetylsalicylic acid—Hypertension—Irinotecan—lung cancer	0.000109	0.00141	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Epirubicin—Doxorubicin—lung cancer	0.000108	0.0353	CbGdCrCtD
Acetylsalicylic acid—NFKBIA—Idarubicin—Doxorubicin—lung cancer	0.000108	0.0353	CbGdCrCtD
Acetylsalicylic acid—NFKBIA—Daunorubicin—Doxorubicin—lung cancer	0.000108	0.0353	CbGdCrCtD
Acetylsalicylic acid—Mefenamic acid—PTGS2—lung cancer	0.000107	0.0389	CrCbGaD
Acetylsalicylic acid—Hypersensitivity—Topotecan—lung cancer	0.000107	0.00139	CcSEcCtD
Acetylsalicylic acid—Hypertension—Gemcitabine—lung cancer	0.000106	0.00138	CcSEcCtD
Acetylsalicylic acid—PTGS1—lymph node—lung cancer	0.000106	0.00228	CbGeAlD
Acetylsalicylic acid—Anaemia—Cisplatin—lung cancer	0.000106	0.00137	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Gemcitabine—lung cancer	0.000104	0.00136	CcSEcCtD
Acetylsalicylic acid—Chest pain—Gemcitabine—lung cancer	0.000104	0.00136	CcSEcCtD
Acetylsalicylic acid—Diabetes mellitus—Doxorubicin—lung cancer	0.000104	0.00135	CcSEcCtD
Acetylsalicylic acid—Confusional state—Irinotecan—lung cancer	0.000103	0.00135	CcSEcCtD
Acetylsalicylic acid—Pruritus—Topotecan—lung cancer	0.000103	0.00134	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Irinotecan—lung cancer	0.000103	0.00133	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Vinorelbine—lung cancer	0.000103	0.00133	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Vinblastine—lung cancer	0.000102	0.00133	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Cisplatin—lung cancer	0.000102	0.00133	CcSEcCtD
Acetylsalicylic acid—Pruritus—Erlotinib—lung cancer	0.000102	0.00132	CcSEcCtD
Acetylsalicylic acid—PTGS2—lymph node—lung cancer	0.000101	0.00217	CbGeAlD
Acetylsalicylic acid—Shock—Irinotecan—lung cancer	0.000101	0.00131	CcSEcCtD
Acetylsalicylic acid—ABCB1—bone marrow—lung cancer	0.000101	0.00217	CbGeAlD
Acetylsalicylic acid—Vascular purpura—Doxorubicin—lung cancer	0.000101	0.00131	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Irinotecan—lung cancer	0.0001	0.00131	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Docetaxel—lung cancer	0.0001	0.00131	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Gemcitabine—lung cancer	0.0001	0.0013	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Docetaxel—lung cancer	9.98e-05	0.0013	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Topotecan—lung cancer	9.95e-05	0.00129	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Irinotecan—lung cancer	9.92e-05	0.00129	CcSEcCtD
Acetylsalicylic acid—Dizziness—Vinblastine—lung cancer	9.9e-05	0.00129	CcSEcCtD
Acetylsalicylic acid—Convulsion—Cisplatin—lung cancer	9.89e-05	0.00129	CcSEcCtD
Acetylsalicylic acid—Urticaria—Vinorelbine—lung cancer	9.88e-05	0.00129	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Erlotinib—lung cancer	9.85e-05	0.00128	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Gemcitabine—lung cancer	9.79e-05	0.00127	CcSEcCtD
Acetylsalicylic acid—Anaemia—Etoposide—lung cancer	9.67e-05	0.00126	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Gemcitabine—lung cancer	9.66e-05	0.00126	CcSEcCtD
Acetylsalicylic acid—Dizziness—Topotecan—lung cancer	9.62e-05	0.00125	CcSEcCtD
Acetylsalicylic acid—Vomiting—Vinblastine—lung cancer	9.52e-05	0.00124	CcSEcCtD
Acetylsalicylic acid—Dizziness—Erlotinib—lung cancer	9.52e-05	0.00124	CcSEcCtD
Acetylsalicylic acid—Anaemia—Paclitaxel—lung cancer	9.48e-05	0.00123	CcSEcCtD
Acetylsalicylic acid—Renal impairment—Doxorubicin—lung cancer	9.46e-05	0.00123	CcSEcCtD
Acetylsalicylic acid—Agitation—Paclitaxel—lung cancer	9.42e-05	0.00123	CcSEcCtD
Acetylsalicylic acid—Vertigo—Etoposide—lung cancer	9.4e-05	0.00122	CcSEcCtD
Acetylsalicylic acid—Angioedema—Paclitaxel—lung cancer	9.37e-05	0.00122	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Etoposide—lung cancer	9.36e-05	0.00122	CcSEcCtD
Acetylsalicylic acid—Purpura—Doxorubicin—lung cancer	9.35e-05	0.00122	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Cisplatin—lung cancer	9.32e-05	0.00121	CcSEcCtD
Acetylsalicylic acid—Flushing—Docetaxel—lung cancer	9.27e-05	0.00121	CcSEcCtD
Acetylsalicylic acid—Vomiting—Topotecan—lung cancer	9.25e-05	0.0012	CcSEcCtD
Acetylsalicylic acid—Hypoglycaemia—Doxorubicin—lung cancer	9.23e-05	0.0012	CcSEcCtD
Acetylsalicylic acid—Vertigo—Paclitaxel—lung cancer	9.21e-05	0.0012	CcSEcCtD
Acetylsalicylic acid—Syncope—Paclitaxel—lung cancer	9.2e-05	0.0012	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Etoposide—lung cancer	9.19e-05	0.0012	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Paclitaxel—lung cancer	9.18e-05	0.00119	CcSEcCtD
Acetylsalicylic acid—Rash—Topotecan—lung cancer	9.17e-05	0.00119	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Vinorelbine—lung cancer	9.17e-05	0.00119	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Topotecan—lung cancer	9.16e-05	0.00119	CcSEcCtD
Acetylsalicylic acid—Vomiting—Erlotinib—lung cancer	9.15e-05	0.00119	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Irinotecan—lung cancer	9.15e-05	0.00119	CcSEcCtD
Acetylsalicylic acid—ABCB1—lung—lung cancer	9.14e-05	0.00197	CbGeAlD
Acetylsalicylic acid—Somnolence—Irinotecan—lung cancer	9.12e-05	0.00119	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Cisplatin—lung cancer	9.12e-05	0.00119	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Cisplatin—lung cancer	9.09e-05	0.00118	CcSEcCtD
Acetylsalicylic acid—Rash—Erlotinib—lung cancer	9.07e-05	0.00118	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Erlotinib—lung cancer	9.07e-05	0.00118	CcSEcCtD
Acetylsalicylic acid—Convulsion—Etoposide—lung cancer	9.06e-05	0.00118	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Irinotecan—lung cancer	9.03e-05	0.00118	CcSEcCtD
Acetylsalicylic acid—Hypertension—Etoposide—lung cancer	9.03e-05	0.00117	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Paclitaxel—lung cancer	9.01e-05	0.00117	CcSEcCtD
Acetylsalicylic acid—Gastrointestinal haemorrhage—Doxorubicin—lung cancer	9.01e-05	0.00117	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Cisplatin—lung cancer	9.01e-05	0.00117	CcSEcCtD
Acetylsalicylic acid—Asthma—Methotrexate—lung cancer	8.99e-05	0.00117	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Gemcitabine—lung cancer	8.91e-05	0.00116	CcSEcCtD
Acetylsalicylic acid—Chest pain—Etoposide—lung cancer	8.9e-05	0.00116	CcSEcCtD
Acetylsalicylic acid—Nausea—Vinblastine—lung cancer	8.89e-05	0.00116	CcSEcCtD
Acetylsalicylic acid—Somnolence—Gemcitabine—lung cancer	8.89e-05	0.00116	CcSEcCtD
Acetylsalicylic acid—Convulsion—Paclitaxel—lung cancer	8.88e-05	0.00116	CcSEcCtD
Acetylsalicylic acid—Hypertension—Paclitaxel—lung cancer	8.85e-05	0.00115	CcSEcCtD
Acetylsalicylic acid—Pruritus—Vinorelbine—lung cancer	8.8e-05	0.00115	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Paclitaxel—lung cancer	8.73e-05	0.00114	CcSEcCtD
Acetylsalicylic acid—Chest pain—Paclitaxel—lung cancer	8.73e-05	0.00114	CcSEcCtD
Acetylsalicylic acid—Nausea—Topotecan—lung cancer	8.64e-05	0.00112	CcSEcCtD
Acetylsalicylic acid—Salicylic acid—PTGS2—lung cancer	8.61e-05	0.0312	CrCbGaD
Acetylsalicylic acid—Confusional state—Etoposide—lung cancer	8.61e-05	0.00112	CcSEcCtD
Acetylsalicylic acid—Nausea—Erlotinib—lung cancer	8.55e-05	0.00111	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Etoposide—lung cancer	8.54e-05	0.00111	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Vinorelbine—lung cancer	8.51e-05	0.00111	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Irinotecan—lung cancer	8.46e-05	0.0011	CcSEcCtD
Acetylsalicylic acid—Confusional state—Paclitaxel—lung cancer	8.44e-05	0.0011	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Paclitaxel—lung cancer	8.37e-05	0.00109	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Etoposide—lung cancer	8.36e-05	0.00109	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Etoposide—lung cancer	8.33e-05	0.00108	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Cisplatin—lung cancer	8.31e-05	0.00108	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Etoposide—lung cancer	8.25e-05	0.00107	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Gemcitabine—lung cancer	8.24e-05	0.00107	CcSEcCtD
Acetylsalicylic acid—Shock—Paclitaxel—lung cancer	8.23e-05	0.00107	CcSEcCtD
Acetylsalicylic acid—Dizziness—Vinorelbine—lung cancer	8.23e-05	0.00107	CcSEcCtD
Acetylsalicylic acid—Hypokalaemia—Doxorubicin—lung cancer	8.2e-05	0.00107	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Paclitaxel—lung cancer	8.19e-05	0.00107	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Paclitaxel—lung cancer	8.17e-05	0.00106	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Paclitaxel—lung cancer	8.09e-05	0.00105	CcSEcCtD
Acetylsalicylic acid—Anaemia—Docetaxel—lung cancer	8.03e-05	0.00105	CcSEcCtD
Acetylsalicylic acid—Drowsiness—Methotrexate—lung cancer	8.02e-05	0.00104	CcSEcCtD
Acetylsalicylic acid—Vomiting—Vinorelbine—lung cancer	7.91e-05	0.00103	CcSEcCtD
Acetylsalicylic acid—Rash—Vinorelbine—lung cancer	7.85e-05	0.00102	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Vinorelbine—lung cancer	7.84e-05	0.00102	CcSEcCtD
Acetylsalicylic acid—Syncope—Docetaxel—lung cancer	7.79e-05	0.00101	CcSEcCtD
Acetylsalicylic acid—Asthma—Doxorubicin—lung cancer	7.79e-05	0.00101	CcSEcCtD
Acetylsalicylic acid—Influenza—Doxorubicin—lung cancer	7.79e-05	0.00101	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Docetaxel—lung cancer	7.78e-05	0.00101	CcSEcCtD
Acetylsalicylic acid—Sweating—Methotrexate—lung cancer	7.69e-05	0.001	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Cisplatin—lung cancer	7.68e-05	0.000999	CcSEcCtD
Acetylsalicylic acid—Salicylic acid—ALB—lung cancer	7.67e-05	0.0278	CrCbGaD
Acetylsalicylic acid—Loss of consciousness—Docetaxel—lung cancer	7.64e-05	0.000994	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Etoposide—lung cancer	7.61e-05	0.00099	CcSEcCtD
Acetylsalicylic acid—Somnolence—Etoposide—lung cancer	7.59e-05	0.000987	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Irinotecan—lung cancer	7.56e-05	0.000983	CcSEcCtD
Acetylsalicylic acid—Convulsion—Docetaxel—lung cancer	7.53e-05	0.00098	CcSEcCtD
Acetylsalicylic acid—Hypertension—Docetaxel—lung cancer	7.5e-05	0.000976	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Paclitaxel—lung cancer	7.46e-05	0.000971	CcSEcCtD
Acetylsalicylic acid—Somnolence—Paclitaxel—lung cancer	7.44e-05	0.000968	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Docetaxel—lung cancer	7.4e-05	0.000963	CcSEcCtD
Acetylsalicylic acid—Chest pain—Docetaxel—lung cancer	7.4e-05	0.000963	CcSEcCtD
Acetylsalicylic acid—Nausea—Vinorelbine—lung cancer	7.39e-05	0.000961	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Paclitaxel—lung cancer	7.37e-05	0.000958	CcSEcCtD
Acetylsalicylic acid—Salicylic acid—ABCB1—lung cancer	7.32e-05	0.0265	CrCbGaD
Acetylsalicylic acid—Haemoglobin—Methotrexate—lung cancer	7.23e-05	0.000941	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Methotrexate—lung cancer	7.2e-05	0.000936	CcSEcCtD
Acetylsalicylic acid—Confusional state—Docetaxel—lung cancer	7.15e-05	0.00093	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Docetaxel—lung cancer	7.09e-05	0.000923	CcSEcCtD
Acetylsalicylic acid—Pruritus—Gemcitabine—lung cancer	7.07e-05	0.00092	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Etoposide—lung cancer	7.03e-05	0.000915	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Irinotecan—lung cancer	7.02e-05	0.000913	CcSEcCtD
Acetylsalicylic acid—Shock—Docetaxel—lung cancer	6.98e-05	0.000908	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Docetaxel—lung cancer	6.95e-05	0.000903	CcSEcCtD
Acetylsalicylic acid—Drowsiness—Doxorubicin—lung cancer	6.94e-05	0.000903	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Docetaxel—lung cancer	6.92e-05	0.000901	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Paclitaxel—lung cancer	6.9e-05	0.000897	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Cisplatin—lung cancer	6.86e-05	0.000893	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Gemcitabine—lung cancer	6.84e-05	0.00089	CcSEcCtD
Acetylsalicylic acid—Dizziness—Irinotecan—lung cancer	6.79e-05	0.000883	CcSEcCtD
Acetylsalicylic acid—Urticaria—Etoposide—lung cancer	6.78e-05	0.000882	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Methotrexate—lung cancer	6.71e-05	0.000873	CcSEcCtD
Acetylsalicylic acid—Sweating—Doxorubicin—lung cancer	6.65e-05	0.000866	CcSEcCtD
Acetylsalicylic acid—Urticaria—Paclitaxel—lung cancer	6.65e-05	0.000865	CcSEcCtD
Acetylsalicylic acid—Vomiting—Irinotecan—lung cancer	6.52e-05	0.000849	CcSEcCtD
Acetylsalicylic acid—Rash—Irinotecan—lung cancer	6.47e-05	0.000842	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Irinotecan—lung cancer	6.46e-05	0.000841	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Cisplatin—lung cancer	6.37e-05	0.000829	CcSEcCtD
Acetylsalicylic acid—Vomiting—Gemcitabine—lung cancer	6.36e-05	0.000827	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Docetaxel—lung cancer	6.32e-05	0.000823	CcSEcCtD
Acetylsalicylic acid—Somnolence—Docetaxel—lung cancer	6.31e-05	0.00082	CcSEcCtD
Acetylsalicylic acid—Rash—Gemcitabine—lung cancer	6.3e-05	0.00082	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Gemcitabine—lung cancer	6.3e-05	0.000819	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Etoposide—lung cancer	6.29e-05	0.000818	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Doxorubicin—lung cancer	6.26e-05	0.000815	CcSEcCtD
Acetylsalicylic acid—ABCB1—lymph node—lung cancer	6.25e-05	0.00135	CbGeAlD
Acetylsalicylic acid—Dyspepsia—Docetaxel—lung cancer	6.24e-05	0.000812	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Doxorubicin—lung cancer	6.23e-05	0.000811	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Paclitaxel—lung cancer	6.17e-05	0.000802	CcSEcCtD
Acetylsalicylic acid—Nausea—Irinotecan—lung cancer	6.1e-05	0.000793	CcSEcCtD
Acetylsalicylic acid—Pruritus—Etoposide—lung cancer	6.04e-05	0.000786	CcSEcCtD
Acetylsalicylic acid—Nausea—Gemcitabine—lung cancer	5.94e-05	0.000772	CcSEcCtD
Acetylsalicylic acid—Vomiting—Cisplatin—lung cancer	5.92e-05	0.000771	CcSEcCtD
Acetylsalicylic acid—Pruritus—Paclitaxel—lung cancer	5.92e-05	0.00077	CcSEcCtD
Acetylsalicylic acid—Rash—Cisplatin—lung cancer	5.87e-05	0.000764	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Cisplatin—lung cancer	5.87e-05	0.000763	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Docetaxel—lung cancer	5.85e-05	0.00076	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Etoposide—lung cancer	5.84e-05	0.00076	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Doxorubicin—lung cancer	5.81e-05	0.000756	CcSEcCtD
Acetylsalicylic acid—Anaemia—Methotrexate—lung cancer	5.79e-05	0.000753	CcSEcCtD
Acetylsalicylic acid—Flushing—Doxorubicin—lung cancer	5.78e-05	0.000752	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Paclitaxel—lung cancer	5.73e-05	0.000745	CcSEcCtD
Acetylsalicylic acid—Dizziness—Etoposide—lung cancer	5.64e-05	0.000734	CcSEcCtD
Acetylsalicylic acid—Vertigo—Methotrexate—lung cancer	5.63e-05	0.000732	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Methotrexate—lung cancer	5.61e-05	0.000729	CcSEcCtD
Acetylsalicylic acid—Dizziness—Paclitaxel—lung cancer	5.53e-05	0.00072	CcSEcCtD
Acetylsalicylic acid—Nausea—Cisplatin—lung cancer	5.53e-05	0.00072	CcSEcCtD
Acetylsalicylic acid—Convulsion—Methotrexate—lung cancer	5.43e-05	0.000706	CcSEcCtD
Acetylsalicylic acid—Vomiting—Etoposide—lung cancer	5.43e-05	0.000706	CcSEcCtD
Acetylsalicylic acid—Rash—Etoposide—lung cancer	5.38e-05	0.0007	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Etoposide—lung cancer	5.38e-05	0.000699	CcSEcCtD
Acetylsalicylic acid—Chest pain—Methotrexate—lung cancer	5.33e-05	0.000694	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Methotrexate—lung cancer	5.33e-05	0.000694	CcSEcCtD
Acetylsalicylic acid—Vomiting—Paclitaxel—lung cancer	5.32e-05	0.000692	CcSEcCtD
Acetylsalicylic acid—Rash—Paclitaxel—lung cancer	5.28e-05	0.000686	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Paclitaxel—lung cancer	5.27e-05	0.000686	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Docetaxel—lung cancer	5.23e-05	0.00068	CcSEcCtD
Acetylsalicylic acid—Confusional state—Methotrexate—lung cancer	5.16e-05	0.000671	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Methotrexate—lung cancer	5.11e-05	0.000665	CcSEcCtD
Acetylsalicylic acid—Nausea—Etoposide—lung cancer	5.07e-05	0.00066	CcSEcCtD
Acetylsalicylic acid—Pruritus—Docetaxel—lung cancer	5.02e-05	0.000653	CcSEcCtD
Acetylsalicylic acid—Anaemia—Doxorubicin—lung cancer	5.01e-05	0.000652	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Methotrexate—lung cancer	5.01e-05	0.000651	CcSEcCtD
Acetylsalicylic acid—Agitation—Doxorubicin—lung cancer	4.99e-05	0.000648	CcSEcCtD
Acetylsalicylic acid—Nausea—Paclitaxel—lung cancer	4.97e-05	0.000647	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Methotrexate—lung cancer	4.94e-05	0.000643	CcSEcCtD
Acetylsalicylic acid—Vertigo—Doxorubicin—lung cancer	4.87e-05	0.000634	CcSEcCtD
Acetylsalicylic acid—Syncope—Doxorubicin—lung cancer	4.86e-05	0.000633	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Doxorubicin—lung cancer	4.86e-05	0.000632	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Docetaxel—lung cancer	4.85e-05	0.000631	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Doxorubicin—lung cancer	4.77e-05	0.00062	CcSEcCtD
Acetylsalicylic acid—Convulsion—Doxorubicin—lung cancer	4.7e-05	0.000611	CcSEcCtD
Acetylsalicylic acid—Dizziness—Docetaxel—lung cancer	4.69e-05	0.00061	CcSEcCtD
Acetylsalicylic acid—Hypertension—Doxorubicin—lung cancer	4.68e-05	0.000609	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Doxorubicin—lung cancer	4.62e-05	0.000601	CcSEcCtD
Acetylsalicylic acid—Chest pain—Doxorubicin—lung cancer	4.62e-05	0.000601	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Methotrexate—lung cancer	4.56e-05	0.000593	CcSEcCtD
Acetylsalicylic acid—Somnolence—Methotrexate—lung cancer	4.55e-05	0.000591	CcSEcCtD
Acetylsalicylic acid—Vomiting—Docetaxel—lung cancer	4.51e-05	0.000587	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Methotrexate—lung cancer	4.5e-05	0.000585	CcSEcCtD
Acetylsalicylic acid—Rash—Docetaxel—lung cancer	4.47e-05	0.000582	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Docetaxel—lung cancer	4.47e-05	0.000581	CcSEcCtD
Acetylsalicylic acid—Confusional state—Doxorubicin—lung cancer	4.46e-05	0.000581	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Doxorubicin—lung cancer	4.43e-05	0.000576	CcSEcCtD
Acetylsalicylic acid—Shock—Doxorubicin—lung cancer	4.36e-05	0.000567	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Doxorubicin—lung cancer	4.33e-05	0.000564	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Doxorubicin—lung cancer	4.32e-05	0.000562	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Doxorubicin—lung cancer	4.28e-05	0.000557	CcSEcCtD
Acetylsalicylic acid—Nausea—Docetaxel—lung cancer	4.21e-05	0.000548	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Methotrexate—lung cancer	4.21e-05	0.000548	CcSEcCtD
Acetylsalicylic acid—Urticaria—Methotrexate—lung cancer	4.06e-05	0.000528	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Doxorubicin—lung cancer	3.95e-05	0.000513	CcSEcCtD
Acetylsalicylic acid—Somnolence—Doxorubicin—lung cancer	3.94e-05	0.000512	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Doxorubicin—lung cancer	3.9e-05	0.000507	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Methotrexate—lung cancer	3.77e-05	0.00049	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Doxorubicin—lung cancer	3.65e-05	0.000475	CcSEcCtD
Acetylsalicylic acid—Pruritus—Methotrexate—lung cancer	3.62e-05	0.000471	CcSEcCtD
Acetylsalicylic acid—Urticaria—Doxorubicin—lung cancer	3.52e-05	0.000457	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Methotrexate—lung cancer	3.5e-05	0.000455	CcSEcCtD
Acetylsalicylic acid—Dizziness—Methotrexate—lung cancer	3.38e-05	0.00044	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Doxorubicin—lung cancer	3.26e-05	0.000424	CcSEcCtD
Acetylsalicylic acid—Vomiting—Methotrexate—lung cancer	3.25e-05	0.000423	CcSEcCtD
Acetylsalicylic acid—Rash—Methotrexate—lung cancer	3.22e-05	0.000419	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Methotrexate—lung cancer	3.22e-05	0.000419	CcSEcCtD
Acetylsalicylic acid—Pruritus—Doxorubicin—lung cancer	3.13e-05	0.000407	CcSEcCtD
Acetylsalicylic acid—Nausea—Methotrexate—lung cancer	3.04e-05	0.000395	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Doxorubicin—lung cancer	3.03e-05	0.000394	CcSEcCtD
Acetylsalicylic acid—Dizziness—Doxorubicin—lung cancer	2.93e-05	0.000381	CcSEcCtD
Acetylsalicylic acid—Vomiting—Doxorubicin—lung cancer	2.81e-05	0.000366	CcSEcCtD
Acetylsalicylic acid—Rash—Doxorubicin—lung cancer	2.79e-05	0.000363	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Doxorubicin—lung cancer	2.79e-05	0.000363	CcSEcCtD
Acetylsalicylic acid—Nausea—Doxorubicin—lung cancer	2.63e-05	0.000342	CcSEcCtD
Acetylsalicylic acid—CYP2C19—Metabolism—CYP2E1—lung cancer	1.63e-06	1.3e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.63e-06	1.3e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—STK11—lung cancer	1.63e-06	1.29e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—STK11—lung cancer	1.62e-06	1.29e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—KIT—lung cancer	1.62e-06	1.29e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—APC—lung cancer	1.62e-06	1.29e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PIK3CG—lung cancer	1.62e-06	1.29e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—CYP1A1—lung cancer	1.62e-06	1.28e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—NQO1—lung cancer	1.61e-06	1.28e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—ERCC2—lung cancer	1.6e-06	1.27e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—EGF—lung cancer	1.6e-06	1.27e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—EP300—lung cancer	1.59e-06	1.27e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CYP2E1—lung cancer	1.59e-06	1.26e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PIK3CG—lung cancer	1.59e-06	1.26e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—EP300—lung cancer	1.58e-06	1.26e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.58e-06	1.25e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—NQO1—lung cancer	1.58e-06	1.25e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—AKT1—lung cancer	1.58e-06	1.25e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—HRAS—lung cancer	1.57e-06	1.25e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.57e-06	1.24e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—HRAS—lung cancer	1.56e-06	1.24e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—SRC—lung cancer	1.55e-06	1.23e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—POMC—lung cancer	1.54e-06	1.22e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—SRC—lung cancer	1.54e-06	1.22e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.53e-06	1.21e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—BRAF—lung cancer	1.52e-06	1.21e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.52e-06	1.21e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—PIK3CA—lung cancer	1.52e-06	1.21e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—PIK3CA—lung cancer	1.52e-06	1.21e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—POMC—lung cancer	1.52e-06	1.2e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—KIT—lung cancer	1.51e-06	1.2e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—APC—lung cancer	1.51e-06	1.2e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—VEGFA—lung cancer	1.51e-06	1.2e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—GSTP1—lung cancer	1.51e-06	1.2e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—IL6—lung cancer	1.51e-06	1.2e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IL6R—lung cancer	1.5e-06	1.19e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	1.5e-06	1.19e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CREBBP—lung cancer	1.5e-06	1.19e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—GSTP1—lung cancer	1.5e-06	1.19e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—EGF—lung cancer	1.49e-06	1.19e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—NRAS—lung cancer	1.49e-06	1.18e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—IL6—lung cancer	1.49e-06	1.18e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CYP2E1—lung cancer	1.49e-06	1.18e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—STAT3—lung cancer	1.48e-06	1.18e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—NRAS—lung cancer	1.48e-06	1.17e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—CREBBP—lung cancer	1.48e-06	1.17e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—NQO1—lung cancer	1.47e-06	1.17e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—TP53—lung cancer	1.47e-06	1.17e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—TP53—lung cancer	1.47e-06	1.17e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—CAT—lung cancer	1.47e-06	1.17e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—CAT—lung cancer	1.46e-06	1.16e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.46e-06	1.16e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—STK11—lung cancer	1.46e-06	1.16e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.45e-06	1.15e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.44e-06	1.14e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MAP2K1—lung cancer	1.43e-06	1.14e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.43e-06	1.13e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—MAPK3—lung cancer	1.43e-06	1.13e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—ABCB1—lung cancer	1.43e-06	1.13e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PIK3CD—lung cancer	1.42e-06	1.13e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—STK11—lung cancer	1.42e-06	1.13e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—BRAF—lung cancer	1.42e-06	1.13e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—ABCB1—lung cancer	1.42e-06	1.13e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—MAPK3—lung cancer	1.42e-06	1.12e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—HRAS—lung cancer	1.41e-06	1.12e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—HRAS—lung cancer	1.41e-06	1.12e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—IL6R—lung cancer	1.4e-06	1.11e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—TYMS—lung cancer	1.4e-06	1.11e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PIK3CD—lung cancer	1.4e-06	1.11e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CREBBP—lung cancer	1.4e-06	1.11e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—TYMS—lung cancer	1.39e-06	1.11e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—AKT1—lung cancer	1.39e-06	1.1e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—GSTM1—lung cancer	1.39e-06	1.1e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—APOA1—lung cancer	1.39e-06	1.1e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—ALB—lung cancer	1.38e-06	1.1e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—GSTM1—lung cancer	1.38e-06	1.09e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—AKT1—lung cancer	1.37e-06	1.09e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.37e-06	1.08e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—EGFR—lung cancer	1.35e-06	1.07e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—IL6—lung cancer	1.35e-06	1.07e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—IL6—lung cancer	1.35e-06	1.07e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—GSTP1—lung cancer	1.35e-06	1.07e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—MAP2K1—lung cancer	1.34e-06	1.06e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—PIK3CD—lung cancer	1.33e-06	1.05e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—STK11—lung cancer	1.33e-06	1.05e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.33e-06	1.05e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—GSTP1—lung cancer	1.31e-06	1.04e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—CYP1A1—lung cancer	1.31e-06	1.04e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CAT—lung cancer	1.31e-06	1.04e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—CYP1A1—lung cancer	1.31e-06	1.04e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—ERCC2—lung cancer	1.3e-06	1.03e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.3e-06	1.03e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—ERCC2—lung cancer	1.3e-06	1.03e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—KRAS—lung cancer	1.28e-06	1.02e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CAT—lung cancer	1.28e-06	1.02e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MDM2—lung cancer	1.28e-06	1.01e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—ABCB1—lung cancer	1.27e-06	1.01e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—KRAS—lung cancer	1.27e-06	1.01e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—RAF1—lung cancer	1.27e-06	1.01e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PIK3CG—lung cancer	1.27e-06	1e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—ERBB2—lung cancer	1.26e-06	9.98e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—TYMS—lung cancer	1.25e-06	9.94e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.25e-06	9.89e-06	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—AKT1—lung cancer	1.24e-06	9.86e-06	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—AKT1—lung cancer	1.24e-06	9.86e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PIK3CB—lung cancer	1.24e-06	9.85e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MTOR—lung cancer	1.24e-06	9.85e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—GSTM1—lung cancer	1.24e-06	9.82e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—GSTP1—lung cancer	1.23e-06	9.75e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—TYMS—lung cancer	1.22e-06	9.7e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PIK3CB—lung cancer	1.22e-06	9.69e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PTGS2—lung cancer	1.21e-06	9.6e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—GSTM1—lung cancer	1.21e-06	9.59e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—POMC—lung cancer	1.2e-06	9.56e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CAT—lung cancer	1.19e-06	9.48e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CXCL8—lung cancer	1.19e-06	9.46e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—MDM2—lung cancer	1.19e-06	9.44e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.19e-06	9.43e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—RAF1—lung cancer	1.19e-06	9.41e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—PIK3CA—lung cancer	1.18e-06	9.36e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CYP1A1—lung cancer	1.17e-06	9.31e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—CREBBP—lung cancer	1.17e-06	9.31e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—ERBB2—lung cancer	1.17e-06	9.31e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—PIK3CA—lung cancer	1.17e-06	9.29e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—ERCC2—lung cancer	1.16e-06	9.23e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—ABCB1—lung cancer	1.16e-06	9.22e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—PIK3CB—lung cancer	1.16e-06	9.19e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—MTOR—lung cancer	1.16e-06	9.19e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CD4—lung cancer	1.16e-06	9.17e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CYP1A1—lung cancer	1.14e-06	9.09e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—TYMS—lung cancer	1.14e-06	9.06e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CASP3—lung cancer	1.14e-06	9.06e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—TP53—lung cancer	1.14e-06	9.05e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IL2—lung cancer	1.14e-06	9.04e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—ERCC2—lung cancer	1.14e-06	9.01e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—GSTM1—lung cancer	1.13e-06	8.96e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—APOA1—lung cancer	1.13e-06	8.95e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—APOA1—lung cancer	1.12e-06	8.9e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PIK3CD—lung cancer	1.11e-06	8.83e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CCND1—lung cancer	1.11e-06	8.82e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—JUN—lung cancer	1.11e-06	8.8e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—ALB—lung cancer	1.1e-06	8.71e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—HRAS—lung cancer	1.09e-06	8.66e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—HRAS—lung cancer	1.08e-06	8.59e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.08e-06	8.57e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MMP9—lung cancer	1.08e-06	8.56e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CDKN1A—lung cancer	1.07e-06	8.53e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.07e-06	8.52e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PTEN—lung cancer	1.07e-06	8.51e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CYP1A1—lung cancer	1.07e-06	8.49e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—ERCC2—lung cancer	1.06e-06	8.42e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PTEN—lung cancer	1.06e-06	8.38e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IL6—lung cancer	1.04e-06	8.22e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PIK3CG—lung cancer	1.03e-06	8.17e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PIK3CG—lung cancer	1.02e-06	8.12e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—EP300—lung cancer	1.02e-06	8.12e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—APOA1—lung cancer	1.01e-06	7.99e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—EP300—lung cancer	1.01e-06	7.99e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CDKN1A—lung cancer	1e-06	7.96e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—PTEN—lung cancer	1e-06	7.94e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—SRC—lung cancer	9.94e-07	7.89e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—APOA1—lung cancer	9.82e-07	7.8e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—POMC—lung cancer	9.8e-07	7.78e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—POMC—lung cancer	9.74e-07	7.73e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PIK3CB—lung cancer	9.69e-07	7.69e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—VEGFA—lung cancer	9.68e-07	7.69e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	9.64e-07	7.65e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—AKT1—lung cancer	9.63e-07	7.65e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—STAT3—lung cancer	9.59e-07	7.61e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—NRAS—lung cancer	9.57e-07	7.59e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—AKT1—lung cancer	9.56e-07	7.59e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—CREBBP—lung cancer	9.54e-07	7.58e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—EP300—lung cancer	9.54e-07	7.57e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—CREBBP—lung cancer	9.49e-07	7.53e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—SRC—lung cancer	9.28e-07	7.36e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PIK3CG—lung cancer	9.19e-07	7.29e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—APOA1—lung cancer	9.18e-07	7.28e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MAPK3—lung cancer	9.16e-07	7.27e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PIK3CD—lung cancer	9.05e-07	7.18e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PIK3CD—lung cancer	9e-07	7.14e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PIK3CG—lung cancer	8.97e-07	7.12e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—STAT3—lung cancer	8.94e-07	7.1e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—ALB—lung cancer	8.93e-07	7.09e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—NRAS—lung cancer	8.92e-07	7.08e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MYC—lung cancer	8.91e-07	7.07e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	8.79e-07	6.97e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—POMC—lung cancer	8.75e-07	6.94e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—EGFR—lung cancer	8.71e-07	6.92e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—MAPK3—lung cancer	8.55e-07	6.78e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—POMC—lung cancer	8.54e-07	6.78e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CREBBP—lung cancer	8.52e-07	6.76e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PIK3CG—lung cancer	8.38e-07	6.65e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PTEN—lung cancer	8.38e-07	6.65e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CREBBP—lung cancer	8.31e-07	6.6e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—MYC—lung cancer	8.31e-07	6.6e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—KRAS—lung cancer	8.23e-07	6.53e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—EGFR—lung cancer	8.13e-07	6.45e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PIK3CD—lung cancer	8.08e-07	6.41e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—EP300—lung cancer	7.99e-07	6.34e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—POMC—lung cancer	7.97e-07	6.33e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—ALB—lung cancer	7.97e-07	6.33e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PIK3CB—lung cancer	7.89e-07	6.26e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PIK3CD—lung cancer	7.88e-07	6.26e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PIK3CB—lung cancer	7.84e-07	6.22e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PTGS2—lung cancer	7.81e-07	6.2e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—ALB—lung cancer	7.78e-07	6.18e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PTGS2—lung cancer	7.77e-07	6.17e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CREBBP—lung cancer	7.77e-07	6.17e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—KRAS—lung cancer	7.68e-07	6.1e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PIK3CA—lung cancer	7.56e-07	6e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PIK3CA—lung cancer	7.44e-07	5.91e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PIK3CD—lung cancer	7.36e-07	5.85e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TP53—lung cancer	7.32e-07	5.81e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—ALB—lung cancer	7.27e-07	5.77e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—PIK3CA—lung cancer	7.06e-07	5.6e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PIK3CB—lung cancer	7.04e-07	5.59e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—HRAS—lung cancer	7e-07	5.55e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PTGS2—lung cancer	6.98e-07	5.54e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PIK3CB—lung cancer	6.87e-07	5.45e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PTEN—lung cancer	6.82e-07	5.41e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PTGS2—lung cancer	6.81e-07	5.4e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PTEN—lung cancer	6.78e-07	5.38e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IL6—lung cancer	6.7e-07	5.32e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—HRAS—lung cancer	6.53e-07	5.18e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—EP300—lung cancer	6.5e-07	5.16e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—EP300—lung cancer	6.46e-07	5.13e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PIK3CB—lung cancer	6.42e-07	5.1e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PTGS2—lung cancer	6.36e-07	5.05e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—IL6—lung cancer	6.25e-07	4.96e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—AKT1—lung cancer	6.18e-07	4.9e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PTEN—lung cancer	6.08e-07	4.83e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—AKT1—lung cancer	6.08e-07	4.83e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PTEN—lung cancer	5.94e-07	4.71e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PIK3CA—lung cancer	5.91e-07	4.69e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—EP300—lung cancer	5.8e-07	4.61e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—AKT1—lung cancer	5.76e-07	4.58e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—EP300—lung cancer	5.66e-07	4.49e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PTEN—lung cancer	5.55e-07	4.4e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—EP300—lung cancer	5.29e-07	4.2e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—AKT1—lung cancer	4.83e-07	3.83e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PIK3CA—lung cancer	4.81e-07	3.82e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PIK3CA—lung cancer	4.78e-07	3.79e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PIK3CA—lung cancer	4.29e-07	3.41e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PIK3CA—lung cancer	4.19e-07	3.32e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—AKT1—lung cancer	3.93e-07	3.12e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PIK3CA—lung cancer	3.91e-07	3.11e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—AKT1—lung cancer	3.91e-07	3.1e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—AKT1—lung cancer	3.51e-07	2.78e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—AKT1—lung cancer	3.42e-07	2.72e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—AKT1—lung cancer	3.2e-07	2.54e-06	CbGpPWpGaD
